Stocklytics Platform
Asset logo for symbol RXRX
Recursion Pharmaceuticals
RXRX51
$5.92arrow_drop_down4.05%-$0.25
Asset logo for symbol RXRX
RXRX51

$5.92

arrow_drop_down4.05%

AI Deep-Learning Forecast (RXRX)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Recursion Pharmaceuticals (RXRX) Stocklytics Forecast

Recursion Pharmaceuticals, Inc. (RXRX) is a promising biotechnology company that specializes in drug discovery through the use of artificial intelligence and machine learning algorithms. With a focus on developing innovative therapies for a range of diseases, Recursion Pharmaceuticals has garnered significant attention in the industry. As investors look to predict the future performance of RXRX stock, it is important to consider various factors.
One key aspect to analyze is the stock price forecast for Recursion Pharmaceuticals. Based on current trends and market conditions, experts predict a positive outlook for RXRX stock in the coming years. The use of advanced technologies such as AI and machine learning in drug discovery positions Recursion Pharmaceuticals as a frontrunner in the industry. This technological edge is likely to contribute to the company's growth and subsequent increase in stock value.
add Recursion Pharmaceuticals to watchlist

Keep an eye on Recursion Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Recursion Pharmaceuticals (RXRX) stock?

Analysts have set a target price of $15 for Recursion Pharmaceuticals (RXRX), based on forecasts from 26 analysts. The predicted price range extends from a high of $33 to a low of $7. This represents a potential increase of up to 457.43% and a decrease of 18.24% from the current price of $5.92. These forecasts are as of 2022 Mar 24.
help

What are the analyst ratings for Recursion Pharmaceuticals (RXRX) stock?

Currently, there are no analyst ratings available for Recursion Pharmaceuticals (RXRX), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Recursion Pharmaceuticals (RXRX) stock?

At present, there is no AI or machine-learning-based price prediction available for Recursion Pharmaceuticals (RXRX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media